Peptide guide
GLOW: what it is and what the research actually shows
GLOW is a name research-chemical sellers use for one vial that mixes three peptides: GHK-Cu, BPC-157 and TB-500. It is not one peptide, and no published study has tested the three together. Some clinics use the same word for an unrelated skin drip.
Byline: PeptideGauge Editors. Sources checked 2026-08-22. Every claim below links to its PubMed record or FDA page.
Quick facts
- What is in it
- GHK-Cu
- BPC-157
- TB-500 (thymosin beta-4 fragment)
Every peptide seller we checked on 2026-08-22 lists the same three peptides. Watch the name: at least one wellness site uses "GLOW" for a GHK-Cu, glutathione and vitamin C drip, which is a different product. We did not test any vial, so we cannot say what a given one contains.
Seller pages that state this:
- Studied for
- Skin and wound repair (GHK-Cu, TB-500), gut and tendon healing (BPC-157). Almost all of it in cells or animals.
- Studies of the blend itself
- None. A PubMed search on 2026-08-22 for the three peptides together found only two general reviews that discuss them one at a time, and no study that gave them together.
- Human evidence, part by part
- GHK-CuLimited3 human studies foundBPC-157Limited3 human studies foundTB-500 (thymosin beta-4 fragment)Limited2 human studies found
- Approved by the FDA?
- No. See where it stands.
What this page does
- Says what sellers mean by the name
- Lists what was studied, in whom, and what was found
- Grades each study: cells, animals, small human study, or trial
- Links every claim to PubMed or FDA
What it will not do
- Tell you how much to use or how often
- Tell you how to mix it or how much water
- Tell you where to buy it
- Guess where the research is silent
How to read the grades
Each study gets a tag. Cells in a dish means it never touched a living animal. Animals means mice or rats, usually. Small human study means a handful of people with no comparison group. Human trial means people were randomly split into treated and untreated groups, which is the only kind that can show an effect is real. Review and Systematic review sum up other studies. The full rule is on How we check.
GHK-Cu
A small natural peptide (three amino acids) that binds copper. Found in human blood; levels fall with age. Studied mostly for skin and tissue repair.
Human evidence: Limited. 3 human studies found in our search.
What has been studied
| Who or what was studied | What was found, and the catch | Source |
|---|---|---|
| Review | Reviews evidence that GHK-Cu changes the activity of many genes tied to repair and inflammation. Limit: Written by the peptide's discoverer; gene correlations, not patient outcomes. | Pickart 2018 PMID 29986520 |
| Animals | GHK-Cu packed into liposomes sped healing of scald burns in mice. Limit: Burn model, and a special delivery form rather than plain GHK-Cu. | Wang 2017 PMID 28370978 |
| Small human study n = 20 (blood levels only) | People with COPD had lower blood GHK; in mice, GHK-Cu reduced smoke-related muscle loss. Limit: The human part only measured blood levels; the treatment effect is in mice. | Deng 2023 PMID 36905132 |
| Human trial n = 13 people | After laser skin resurfacing, a copper-peptide cream did not beat control on measured redness or wrinkles; patients did report liking it more. Limit: Thirteen people, a cream, one subjective win. | Miller 2006 PMID 16847171 |
| Small human study n = 29 people | A scalp routine with a copper-peptide serum plus a scrub reduced flaking over 15 days. Limit: No control group, company-employed authors, peptide mixed with other actives. | Patel 2024 PMID 39449909 |
Safety signals in the studies
- No skin reactions flagged in the one small trial (a cream). PMID 16847171
- No adverse events over 15 days of a scalp product. PMID 39449909
- We found no published human safety data for injected GHK-Cu; all human data is topical.
BPC-157
A lab-made peptide (15 amino acids) copied from a piece of a protein in human stomach fluid. Studied mostly in rats for gut and tendon healing.
Human evidence: Limited. 3 human studies found in our search.
What has been studied
| Who or what was studied | What was found, and the catch | Source |
|---|---|---|
| Systematic review n = 36 studies, 1 human | Of 36 studies, 35 were in animals, where healing of tendon, ligament, muscle and bone improved. The one human study was small and retrospective. Limit: Review says plainly: no clinical safety data exist for BPC-157. | Vasireddi 2025 PMID 40756949 |
| Animals | Rat tendon cells in a dish grew out and moved more with BPC-157. Limit: Cells only. | Chang 2011 PMID 21030672 |
| Small human study n = 16 people | Patients given BPC-157 for knee pain mostly said they felt better when phoned months later. Limit: No control group, no imaging, relies on memory by phone. | Lee 2021 PMID 34324435 |
| Small human study n = 12 people | Women with stubborn bladder pain reported big improvements after BPC-157. Limit: Twelve people, one clinic, no comparison group. | Lee 2024 PMID 39325560 |
| Small human study n = 2 people | Two adults showed no change in heart, liver, kidney, thyroid or sugar markers after BPC-157. Limit: Two people. Far too few to call anything safe. | Lee 2025 PMID 40131143 |
| Review | Broad activity in animal injury models, but not approved for human use anywhere for lack of clinical data. Limit: Narrative and patent review. | Józwiak 2025 PMID 40005999 |
Safety signals in the studies
- Animal studies show no harm across organs; no human safety data. PMID 40756949
- Placed on the World Anti-Doping Agency prohibited list in 2022; unapproved by regulators. PMID 40005999
- No biomarker changes in a two-person pilot. PMID 40131143
TB-500 (thymosin beta-4 fragment)
Thymosin beta-4 is a natural protein in almost every cell that helps cells move and rebuild. TB-500 is the name sellers use for a lab-made piece of it. Most studies used the full protein, not the fragment.
Human evidence: Limited. 2 human studies found in our search.
What has been studied
| Who or what was studied | What was found, and the catch | Source |
|---|---|---|
| Human trial n = 9 people | Thymosin beta-4 eye drops eased discomfort and surface damage in severe dry eye versus placebo. Limit: Nine people, eye drops, many comparisons. | Sosne 2015 PMID 25826322 |
| Human trial n = 96 people | In a 96-patient heart-attack trial, the main result was not statistically significant; a timing subgroup showed smaller infarcts. Mice showed less heart damage. Limit: Used the full recombinant protein, not the TB-500 fragment sold. | Zhang 2025 PMID 41229390 |
| Review | Summarizes thymosin beta-4's role in cell movement and tissue repair and lists trials then under way. Limit: Author helped develop the compound. | Goldstein 2012 PMID 22074294 |
| Review | Says phase 2 wound trials found faster repair and good tolerability. Limit: Cites the authors' own work; trial reports not separately checked here. | Kleinman 2016 PMID 27450738 |
| Review | How thymosin beta-4 was found as the cell's main actin-binding peptide. Limit: Basic science, not treatment. | Hannappel 2007 PMID 17468232 |
Safety signals in the studies
- Eye drops safe and well tolerated over 56 days in a 9-person trial. PMID 25826322
- We found no human study of the shorter TB-500 fragment that sellers actually offer.
Where it stands with regulators
- All three peptides appear on the FDA's list of bulk drug substances nominated for compounding and then withdrawn, over possible immune reactions and peptide-related impurities. None is an FDA-approved drug. Page last updated 2026-04-22. Source
- A 2025 review states BPC-157 is not approved by the FDA or any other regulator for lack of clinical data, and was put on the World Anti-Doping Agency prohibited list in 2022. Source
What is missing
No study of the blend itself. No large human trial of any part in the form that is sold. No long-term safety data in people for any part. Where this page says "limited," read it as "a few small studies that cannot settle the question."
Common questions
Is GLOW one peptide?
No. It is a seller's name for a mix of three peptides in one vial. Each one has its own research; the mix has none.
Is GLOW the same as the GLOW skin drip some clinics offer?
No. That one is GHK-Cu with glutathione and vitamin C. Same word, different product. Check the label.
Has GLOW been tested in people?
Not as a blend. The three parts have a handful of small human studies, mostly skin creams, eye drops, or the full thymosin protein rather than what is sold.
Is it FDA approved?
No. All three peptides are on the FDA's list of compounding substances that were nominated and withdrawn over safety questions.
Will this page tell me how much to use?
No. We do not publish amounts or schedules for any peptide. That belongs with a licensed doctor.
Sources
- Chang (2011). PMID 21030672
- Deng (2023). PMID 36905132
- Goldstein (2012). PMID 22074294
- Hannappel (2007). PMID 17468232
- Józwiak (2025). PMID 40005999
- Kleinman (2016). PMID 27450738
- Lee (2021). PMID 34324435
- Lee (2024). PMID 39325560
- Lee (2025). PMID 40131143
- Miller (2006). PMID 16847171
- Patel (2024). PMID 39449909
- Pickart (2018). PMID 29986520
- Sosne (2015). PMID 25826322
- Vasireddi (2025). PMID 40756949
- Wang (2017). PMID 28370978
- Zhang (2025). PMID 41229390
FDA list of bulk drug substances nominated for compounding and withdrawn, last updated 2026-04-22: fda.gov.
Mixing a vial? Do the math with the calculator.
Open the calculator